2nd ISV COVID-19 Vaccines Virtual Congress

The International Society for Vaccines (ISV) (www.isv-online.org) is pleased to announce the 2nd Congress of the ISV Virtual Congress Series on COVID-19 Vaccines will be held on July 21, Tuesday.

The Virtual Congress series provides a platform for key COVID-19 vaccine developers to share their progress and for the global vaccine community to contribute their collective wisdom so the entire global community can enjoy the benefits of vaccine protection in the near future.

The final program is online at https://www.isvcongress.org/ and registration is OPEN!

The 2nd Virtual Congress will present to the global vaccine community another great speaker panel:

  • The opening keynote speaker,  Larry Corey from Fred Hutchinson Cancer Research Center, will describe the clinical study design of COVID-19 which is an unprecedented challenge in the history of vaccinology.
  • The second keynote speaker,  Marion Gruber from US FDA, will provide an overview on the regulatory review of COVID-19 vaccines.
  • Greg Glenn (Novavax), George Gao (China CDC), Hanneke Schuitemaker (J&J/Janssen) and Kena Swanson (Pfizer) will present the progress of their respective COVID-19 vaccine programs.
  • The final panel discussion will include world experts Stanley Perlman (University of Iowa; moderator), Bart Haagmans (Erasmus University), Vincent Munster (RML/NIH) and Linda Saif (The Ohio State University) to discuss the value of animal models for the development of COVID-19 vaccines.

The July 21 Congress is free to worldwide scientists with an interest in COVID-19 vaccines.  Pre-registration is required.  Space is limited and ISV members will have priority.

Register now at www.ISVCongress.org.

The first Congress on June 22 was a huge success with 1600 registered attendees. Professor Kwok-Hung Yuen from Hong Kong University and Dr. Nick Jackson from CEPI provided the keynote speeches.  Representatives from NIAID, INOVIO, University of Oxford and CanSinoBIO presented the progress of their respective COVID-19 vaccine programs.  A special expert panel discussed the value and limitation of human challenge studies.

A full set of video recordings of the 1st ISV Virtual Congress is available at YouTube:  https://www.youtube.com/channel/UC9_-f8tDAqOmVEZWqGeuFow